TNNC2
Troponin C, skeletal muscle
As of the edition of 20 October 2026, TNNC2 (troponin C, skeletal muscle, UniProt P02585) has 2 drugs tested at it and 2 companies on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P02585
- How well studied
- Biology documented; no tool compounds or approved drug yet
- Solved structures
- 1
- Disease areas
- Nervous system; Nutrition and metabolism; Cancer; Heart and blood vessels; Immune system; Lungs and airways
- Registered trials of its drugs
- 14
Drugs at this target
| Status | Count |
|---|---|
| Went quiet | 1 |
| Stopped | 1 |
| Total | 2 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Tirasemtiv | Went quiet | Phase 3 | none listed |
| Reldesemtiv | Stopped | Phase 3 | none listed |
2 of 2 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Undetermined | 2 |
| Total on the list | 2 |